Kokilaben Hospital Opens A Hereditary Cancer Clinic To Offer Personalised Cancer Care

At the International Symposium on Precision Oncology and Personalised Medicine, Kokilaben Dhirubhai Ambani Hospital, a pioneer in introducing the latest medical advancements and cutting-edge technologies in cancer care, the hospital announced the launch of its dedicated hereditary cancer clinic. Precision oncology has the potential to greatly reduce the burden of cancer by enhancing the effectiveness of cancer treatment, with an estimated 1.4 million new instances of cancer diagnosed each year in India and a high incidence of the illness.

Hereditary testing, an important part of precision oncology, allows for the identification of gene mutations in an individual and his family, providing information into the likelihood of acquiring cancer even before symptoms appear. It is particularly useful in creating cancer. Panel discussions provided fascinating insights on recent developments and innovative treatment options in cancer care, as well as the future of precision oncology, during the conference, which brought together renowned oncologists, researchers, and medical professionals from across the world. Precision oncology is a novel method to cancer treatment in which tumours are profiled at the molecular level and mutations are identified so that personalised treatment can be specifically tailored and targeted to an individual patient's unique form of cancer.

Precision medicine guarantees that the appropriate cancer treatment is administered to the appropriate patient at the appropriate dose and at the appropriate time. Precision oncology, also known as personalised cancer treatment, entails using cutting-edge technology and in-depth genomic insights to adapt treatment strategies to each patient's unique genetic makeup and disease features. Kokilaben Hospital has been in the vanguard of this strategy, providing comprehensive care that covers all aspects of a patient's cancer journey.

The hereditary cancer clinic is an important part of this approach, providing comprehensive genetic counselling and testing to detect and treat genetic risk factors associated with various malignancies. The symposium also included a felicitation ceremony with Tina Anil Ambani, chairperson of Kokilaben Hospital honouring eminent doctors and achievers in the field of oncology from across India and the world. "Cancer care is an overarching priority for Kokilaben Hospital, which has always been ahead of the curve in terms of technology and talent," Ambani explained.

We acknowledge that precision oncology and personalised medicine are the next frontiers in cancer care and are excited to organise this symposium, which will give a wealth of information, a place for discourse, an opportunity for contact, and a platform to recognise excellence. On this occasion, I am also pleased to announce that we will continue to focus on precision oncology and personalised treatment by establishing a hereditary cancer clinic, which will assist anticipate familial cancer risk and conduct preventive steps.

This is a big step forward in our mission to "Contain, Combat, and Conquer Cancer." "Kokilaben Hospital has remained ahead of the curve and in line with the best global practises in cancer care," stated Dr. Santosh Shetty, CEO and executive director of Kokilaben Dhirubhai Ambani Hospital. Our commitment to investing in cutting-edge technology and research demonstrates our commitment to promoting personalised cancer care. The hereditary cancer clinic exemplifies our unwavering commitment to precision oncology.

The installation of the new clinic is a testament to the largest commitment by any single institute in cancer, with a diverse team of experienced professionals, cutting-edge facilities, and the latest technologies, and is projected to make a substantial difference in cancer outcomes." Kokilaben Hospital has been at the forefront of precision oncology in India, consistently introducing innovative technologies and treatment options to deliver world-class cancer care. With active cancer care centres across Maharashtra in Akola, Gondia, and Solapur, the Institute has a skilled team of more than 45 consultants and 225 members in the oncology team. The team has administered over 175,000 chemotherapies, 6 lakh radiation cycles, and performed 63,000 surgeries.

The introduction of the EDGE radiosurgery system was a landmark contribution to bring international innovations accessible to cancer patients in India. Installation of True Beam equipment was another cutting-edge approach to precision oncology. There are a number of full-time subspecialists skilled in handling the widest range of cancers who provide a broad range of cancer services, from public education, screening, and diagnosis to treatment, pain management, and palliative care.